PtdIns5P and Pin1 in oxidative stress signaling

Advances in Biological Regulation

Volumn 53, Issue 2, 2013, Pages 179-189

  Keune, Willem Jan ^a   Jones, David R ^a   Divecha, Nullin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE; MUS;

EID: 84878608998     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2013.02.001     Document Type: Review

References (86)

1. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996, 15:6541-6551.
2. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006, 6:37-46.
3. Banci L., Bertini I., Boca M., Girotto S., Martinelli M., Valentine J.S., et al. SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PLoS One 2008, 3:e1677.
4. Bazenet C.E., Ruano A.R., Brockman J.L., Anderson R.A. The human erythrocyte contains two forms of phosphatidylinositol-4-phosphate 5-kinase which are differentially active toward membranes. J Biol Chem 1990, 265:18012-18022.
5. Berridge M.J., Irvine R.F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984, 312:315-321.
6. Blind R.D., Suzawa M., Ingraham H.A. Direct modification and activation of a nuclear receptor-PIP(2) complex by the inositol lipid kinase IPMK. Sci Signal 2012, 5:ra44.
7. Boronenkov I.V., Anderson R.A. The sequence of phosphatidylinositol-4-phosphate 5-kinase defines a novel family of lipid kinases. J Biol Chem 1995, 270:2881-2884.
8. Boronenkov I.V., Loijens J.C., Umeda M., Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 1998, 9:3547-3560.
9. Brenkman A.B., de Keizer P.L., van den Broek N.J., van der Groep P., van Diest P.J., van der Horst A., et al. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res 2008, 68:7597-7605.
10. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
11. Bultsma Y., Keune W.J., Divecha N. PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha. Biochem J 2010, 430:223-235.
12. Burden L.M., Rao V.D., Murray D., Ghirlando R., Doughman S.D., Anderson R.A., et al. The flattened face of type II beta phosphatidylinositol phosphate kinase binds acidic phospholipid membranes. Biochemistry 1999, 38:15141-15149.
13. Castellino A.M., Parker G.J., Boronenkov I.V., Anderson R.A., Chao M.V. A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem 1997, 272:5861-5870.
14. Chakraborty A., Kim S., Snyder S.H. Inositol pyrophosphates as mammalian cell signals. Sci Signal 2011, 4:re1.
15. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 1998, 332(Pt 1):43-50.
16. Ciruela A., Hinchliffe K.A., Divecha N., Irvine R.F. Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7. Biochem J 2000, 346(Pt 3):587-591.
17. Clarke J.H., Emson P.C., Irvine R.F. Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron. Am J Physiol Ren Physiol 2008, 295:F1422-F1430.
18. Clarke J.H., Emson P.C., Irvine R.F. Distribution and neuronal expression of phosphatidylinositol phosphate kinase IIgamma in the mouse brain. J Comp Neurol 2009, 517:296-312.
19. Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 2008, 31:438-448.
20. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
21. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443:651-657.
22. Divecha N., Brooksbank C.E., Irvine R.F. Purification and characterization of phosphatidylinositol 4-phosphate 5-kinases. Biochem J 1992, 288(Pt 2):637-642.
23. Emerit J., Edeas M., Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004, 58:39-46.
24. Fanghanel J., Fischer G. Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front Biosci 2004, 9:3453-3478.
25. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
26. Fischer L.R., Igoudjil A., Magrane J., Li Y., Hansen J.M., Manfredi G., et al. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain 2011, 134:196-209.
27. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
28. Greer E.L., Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005, 24:7410-7425.
29. Halstead J.R., Jalink K., Divecha N. An emerging role for PtdIns(4,5)P2-mediated signalling in human disease. Trends Pharmacol Sci 2005, 26:654-660.
30. Hanes S.D., Shank P.R., Bostian K.A. Sequence and mutational analysis of ESS1, a gene essential for growth in Saccharomyces cerevisiae. Yeast 1989, 5:55-72.
31. Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 2010, 13:1713-1748.
32. Hinchliffe K.A., Ciruela A., Letcher A.J., Divecha N., Irvine R.F. Regulation of type IIalpha phosphatidylinositol phosphate kinase localisation by the protein kinase CK2. Curr Biol 1999, 9:983-986.
33. Hinchliffe K.A., Irvine R.F. Regulation of type II PIP kinase by PKD phosphorylation. Cell Signal 2006, 18:1906-1913.
34. Hsu T., McRackan D., Vincent T.S., Gert de Couet H. Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat Cell Biol 2001, 3:538-543.
35. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997, 275:1649-1652.
36. Irvine R.F. Nuclear lipid signalling. Nat Rev Mol Cell Biol 2003, 4:349-360.
37. Itoh T., Ijuin T., Takenawa T. A novel phosphatidylinositol-5-phosphate 4-kinase (phosphatidylinositol-phosphate kinase IIgamma) is phosphorylated in the endoplasmic reticulum in response to mitogenic signals. J Biol Chem 1998, 273:20292-20299.
38. Jones D.R., Bultsma Y., Keune W.J., Halstead J.R., Elouarrat D., Mohammed S., et al. Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta. Mol Cell 2006, 23:685-695.
39. Jones D.R., Foulger R., Keune W.J., Bultsma Y., Divecha N. PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation. FASEB J 2013, 27:1644-1656.
40. Keune W.J., Jones D.R., Bultsma Y., Sommer L., Zhou X.Z., Lu K.P., et al. Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress. Sci Signal 2012, 5:ra86.
41. Kim S.E., Lee M.Y., Lim S.C., Hien T.T., Kim J.W., Ahn S.G., et al. Role of Pin1 in neointima formation: down-regulation of Nrf2-dependent heme oxygenase-1 expression by Pin1. Free Radic Biol Med 2010, 48:1644-1653.
42. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139.
43. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
44. Lee S.R., Kwon K.S., Kim S.R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 1998, 273:15366-15372.
45. 2. J Biol Chem 2002, 277:20336-20342.
46. Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 2008, 9:99-111.
47. Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 2003, 22:5501-5510.
48. Ling L.E., Schulz J.T., Cantley L.C. Characterization and purification of membrane-associated phosphatidylinositol-4-phosphate kinase from human red blood cells. J Biol Chem 1989, 264:5080-5088.
49. Liou Y.C., Ryo A., Huang H.K., Lu P.J., Bronson R., Fujimori F., et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci U S A 2002, 99:1335-1340.
50. Liou Y.C., Sun A., Ryo A., Zhou X.Z., Yu Z.X., Huang H.K., et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424:556-561.
51. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
52. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 2007, 8:904-916.
53. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
54. Maher J., Yamamoto M. The rise of antioxidant signaling - the evolution and hormetic actions of Nrf2. Toxicol Appl Pharmacol 2010, 244:4-15.
55. McCrea H.J., De Camilli P. Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 2009, 24:8-16.
56. McMahon M., Itoh K., Yamamoto M., Hayes J.D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003, 278:21592-21600.
57. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
58. Monserrate J.P., York J.D. Inositol phosphate synthesis and the nuclear processes they affect. Curr Opin Cell Biol 2010, 22:365-373.
59. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
60. Paulsen C.E., Carroll K.S. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol 2010, 5:47-62.
61. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007, 315:659-663.
62. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
63. Rameh L.E., Tolias K.F., Duckworth B.C., Cantley L.C. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 1997, 390:192-196.
64. Ranganathan R., Lu K.P., Hunter T., Noel J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886.
65. Rao V.D., Misra S., Boronenkov I.V., Anderson R.A., Hurley J.H. Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation. Cell 1998, 94:829-839.
66. Rippmann J.F., Hobbie S., Daiber C., Guilliard B., Bauer M., Birk J., et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 2000, 11:409-416.
67. Ryo A., Hirai A., Nishi M., Liou Y.C., Perrem K., Lin S.C., et al. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J Biol Chem 2007, 282:36671-36681.
68. Ryo A., Liou Y.C., Wulf G., Nakamura M., Lee S.W., Lu K.P. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002, 22:5281-5295.
69. Saiardi A. Cell signalling by inositol pyrophosphates. Subcell Biochem 2012, 59:413-443.
70. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
71. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R., Reese C.B., Painter G.F., et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 1997, 277:567-570.
72. Stone J.R., Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 2006, 8:243-270.
73. Sykes S.M., Lane S.W., Bullinger L., Kalaitzidis D., Yusuf R., Saez B., et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 2011, 146:697-708.
74. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1005-L1028.
75. Theuerkorn M., Fischer G., Schiene-Fischer C. Prolyl cis/trans isomerase signalling pathways in cancer. Curr Opin Pharmacol 2011, 11:281-287.
76. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
77. Wang M., Bond N.J., Letcher A.J., Richardson J.P., Lilley K.S., Irvine R.F., et al. Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIalpha and IIbeta and a partial nuclear localization of the IIalpha isoform. Biochem J 2010, 430:215-221.
78. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006, 5:14.
79. Weinberg F., Hamanaka R., Wheaton W.W., Weinberg S., Joseph J., Lopez M., et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 2010, 107:8788-8793.
80. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008, 9:162-176.
81. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
82. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat Rev Cancer 2007, 7:381-388.
83. You H., Zheng H., Murray S.A., Yu Q., Uchida T., Fan D., et al. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J Cell Biochem 2002, 84:211-216.
84. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
85. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419:849-853.
86. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 2000, 6:873-883.